A detailed history of Financial Advisory Group transactions in Novo Nordisk A S stock. As of the latest transaction made, Financial Advisory Group holds 4,514 shares of NVO stock, worth $383,690. This represents 0.1% of its overall portfolio holdings.

Number of Shares
4,514
Previous 4,490 0.53%
Holding current value
$383,690
Previous $464,000 24.78%
% of portfolio
0.1%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $2,450 - $3,262
24 Added 0.53%
4,514 $579,000
Q3 2023

Dec 07, 2023

BUY
$90.94 - $199.54 $204,160 - $447,967
2,245 Added 100.0%
4,490 $408,000
Q3 2021

Nov 09, 2021

BUY
$84.42 - $106.62 $189,522 - $239,361
2,245 New
2,245 $216,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Financial Advisory Group Portfolio

Follow Financial Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisory Group with notifications on news.